Wednesday, August 26, 2026 | 1:00–2:00 PM EDT | Virtual
Contact Hours: 1.0
Target Audience: Pharmacists
UAN: 0217-0000-26-063-L04-P
Activity Type: Knowledge
Fees & Registration
Drug Information and/or Health Equity PRN Members: $0.00
ACCP Members: $10.00
Non-ACCP Members: $20.00
|
Register Now |
Description:
The Drug Information PRN and Health Equity PRN present this engaging session addressing the intersection of medical misinformation, generative artificial intelligence (AI), and health equity. This collaborative session addresses areas of need and challenges identified from the Drug Information member survey and results from the Health Equity PRN project mapping health equity integration across ACCP PRNs. The Drug Information PRN members’ feedback highlighted challenges in AI benefits and dangers, best practices, combatting misinformation and integrating health equity measures in drug information. Furthermore, in the Health Equity PRN mapping project, of the 27 PRNs that completed the survey, 13 (81.3%) indicated none/not discussed/NA to “What best practices does your PRN recommend for the responsible integration and use of AI to reduce stigma or bias?” Collectively, this CE session will be 1 hour on August 26, from 1 PM-2 PM EDT composed of 2 presentations by Drs. Faria Munir and Sally Arif. Dr. Munir will discuss how generative AI shapes medical misinformation and apply structured evaluation and communication strategies to verify accuracy and counter misinformation effectively. Dr. Arif will discuss the impact of misinformation on vulnerable populations and integrate health equity and ethical AI principles into drug information practices to support unbiased, evidence-based communication.
Learning Objectives:
- Discuss the influence of generative AI on the creation and dissemination of medical misinformation.
- Identify structured literature evaluation tools to verify accuracy in the digital era.
- Review best practices to counter misinformation and support equitable patient education and evidence-based
communication.
- Describe the impact of misinformation on vulnerable populations and health inequities.
- Identify strategies for integrating health equity principles into drug information, communication, and decision-making.
- Discuss responsible and ethical approaches for incorporating AI tools into the drug information process to
minimize bias, reduce stigma, and enhance the quality of evidence-based communication.
Moderator:
Maha Abdalla, Pharm.D., Ph.D.
Professor, South College Director of Health Affairs
South College School of Pharmacy
Knoxville, Tennessee
Speakers:
Faria Munir, Pharm.D., MS, BCPS
Medical Review Manager
Xeris Pharmaceuticals
Chicago, Illinois
Sally Arif, Pharm.D., BCCP, BCPS
Professor of Pharmacy Practice, Downers Grover Cardiology Clinical Pharmacist
Midwestern University College of Pharmacy
Technical Requirements
This webinar will be conducted on Zoom. View Zoom System Requirements.
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To obtain your CPE credit after the event, please visit www.accp.com, sign in, and complete the attestation statement related to this activity. You must claim your CPE by October 25, 2026. Statements of credit will be available via CPE Monitor within 2–3 business days of claiming credit. ACCP cannot issue CPE credit to any participant who does not have a date of birth and NABP e-Profile ID number on file with ACCP. Credit will not be awarded after October 25, 2026.